Profile
BJDX ABT BSX-PA SYK BSX MDT
Company Name Bluejay Diagnostics, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Boston Scientific Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $1.17M $197.08B $175.45B $137.35B $120.45B $113.61B
Employees 0.01K 114.00K 45.00K 52.00K 48.00K 95.00K
CEO Mr. Indranil Dey Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Michael F. Mahoney Mr. Geoffrey Straub Martha
Ratings
BJDX ABT BSX-PA SYK BSX MDT
Quant Rating Score 3 3 3 3 3
Quant Rating Neutral Neutral Neutral Neutral Neutral
Trading
BJDX ABT BSX-PA SYK BSX MDT
Last Close $0.1867 $113.27 $122.18 $360.42 $81.79 $88.58
High 52 $5.73 $120.98 $122.18 $360.42 $81.79 $89.34
Low 52 $0.19 $90.19 $122.18 $253.85 $48.64 $69.43
Price vs. 52 Week High -96.74 % -6.37 % 0 % 0 % 0 % -0.85 %
Price vs. 52 Week Low -1.74 % 25.59 % 0 % 41.98 % 68.15 % 27.58 %
Total Return
BJDX ABT BSX-PA SYK BSX MDT
1 Month Return -62.66 % 2.83 % 0 % 8.18 % 8.82 % 10.05 %
3 Month Return -64.77 % 10.84 % 0 % 5.67 % 8.23 % 8.86 %
6 Month Return -77.23 % -4.51 % 0 % 2.04 % 21.84 % 5.96 %
9 Month Return -94.2 % 8 % 0 % 21.03 % 45.69 % 10.74 %
YTD Return -84.7 % 2.91 % 0 % 20.36 % 41.48 % 7.53 %
1 Year Return -96.69 % 10.13 % 0 % 26.71 % 52.54 % 7.85 %
3 Year Return 0 % -11.09 % 0 % 0 % 79.44 % -33.98 %
5 Year Return 0 % 34.75 % 0 % 0 % 96.28 % -17.58 %
Dividends
BJDX ABT BSX-PA SYK BSX MDT
Dividend Yield Percentage (TTM) - 1.91 % - 0.87 % - 3.13 %
Dividend Paid and Capex Coverage Ration (TTM) -17.21 % 1.33 % 2.66 % 1.91 % 3.01 % 1.28 %
Dividend Per Share (TTM) - 2.16 % - 3.15 % - 2.77 %
Payout Ratio (TTM) - 66.47 % 6.1 % 34.19 % - 92.84 %
Growth
BJDX ABT BSX-PA SYK BSX MDT
Asset Growth -63.99 % -1.64 % 8.21 % 8.21 % 8.21 % -1.06 %
Gross Profit Growth -1696.69 % -9.7 % 14.01 % 12.78 % 14.01 % -5.14 %
Revenue Growth -100 % -8.12 % 12.29 % 11.11 % 12.29 % 3.64 %
Revenue 3 Year - 18.09 % 40.06 % 41.29 % 40.06 % 8.85 %
Revenue 5 Year - 32.35 % 37.78 % 48.53 % 37.78 % 7.41 %
Revenue 10 Year - 63.34 % 84.02 % 126.63 % 84.02 % 43.65 %
EBIT Growth -10.66 % -22.53 % 42.09 % 36.85 % 42.09 % 4.5 %
Net Income Growth -7.87 % -17.45 % 128.22 % 34.22 % 128.22 % -2.18 %
Net Income 3 Yeari Growth Per Share -3994.72 % 29.73 % 1209.43 % 95.8 % 1209.43 % 3.26 %
Net Income 5 Yeari Growth Per Share -5983.4 % 143.85 % -9.39 % -12.21 % -9.39 % -19.5 %
Net Income 10 Yeari Growth Per Share -5983.4 % 97.66 % 1315.23 % 213.78 % 1315.23 % -9.48 %
Operating Income Growth -10.66 % -22.53 % 42.09 % 36.85 % 42.09 % 4.5 %
Operating Cash Flow Growth (CFG) -7.39 % -24.21 % 64.02 % 41.43 % 64.02 % 12.39 %
Operating 3 Year CFG -7468.21 % -6.36 % 61.83 % 12.02 % 61.83 % 10.18 %
Operating 5 Year CFG -2177.96 % 16.29 % 667.41 % 40.12 % 667.41 % -1.78 %
Operating 10 Year CFG -2177.96 % 94.35 % 113.53 % 96.25 % 113.53 % 3.3 %
EPS Growth -693.66 % -16.24 % 140 % 33.87 % 140 % -2.12 %
EPS Diluted Growth -693.66 % -16.62 % 137.78 % 33.71 % 137.78 % -2.13 %
Book Value Per Share 84.5 % 6.01 % 8.01 % 11.49 % 8.01 % -2.31 %
Share Holder 3 Year Equity Growth Per Share 418.71 % 19.98 % 22.65 % 40.57 % 22.65 % -1.1 %
Share Holder 5 Year Equity Growth Per Share 557.15 % 27.6 % 110.04 % 56.21 % 110.04 % 1.66 %
Share Holder 10 Year Equity Growth Per Share 557.15 % 36.45 % 172.17 % 104.97 % 172.17 % 94.93 %
Dividend Per Share Growth - 8.27 % -49.88 % 7.97 % -49.88 % 1.54 %
Dividend 3 Year Growth Per Share - 41.54 % -2.5 % 30.56 % -2.5 % 19.02 %
Dividend 5 Year Growth Per Share - 81.76 % - 59.67 % - 38.05 %
Dividend 10 Year Growth Per Share - 258.71 % - 183.29 % - 147.94 %
Debt Growth -24.87 % -10.4 % 2.26 % -0.41 % 2.26 % 6.91 %
Free Cash Flow Growth -0.86 % -35.17 % 86.32 % 54.03 % 86.32 % 13.54 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 26 Apr 2024
Profitability
BJDX ABT BSX-PA SYK BSX MDT
Gross Profit Margin TTM 69.97 % 54.38 % 68.75 % 62.5 % 67.15 % 62.74 %
Return on Assets TTM -86.6 % 7.61 % 2.74 % 8.81 % 4.92 % 4.38 %
Return on Equity TTM -187 % 14.41 % 5.13 % 18.28 % 9.3 % 7.8 %
Return on Capital Employed TTM -102.83 % 11.49 % 6.66 % 13.42 % 8.62 % 7.19 %
Net Income Per EBT TTM 100 % 85.37 % 63.08 % 85.86 % 85.16 % 80 %
EBT Per Ebit TTM 103.9 % 95.64 % 74.52 % 92.92 % 78.87 % 85.93 %
EBIT Per Revenue TTM -624.55 % 16.71 % 14.71 % 20.21 % 17.84 % 17.54 %
Cash Flow To Debt Ratio TTM -1865.42 % 53.54 % 18.94 % 27.62 % 24.91 % 24.8 %
Receivables Turnover TTM - 5.94 6.28 5.91 6.35 5.42
Payables Turnover TTM 0.89 4.5 4.7 6.15 5.52 5.3
Inventory Turnover TTM - 2.73 1.99 1.59 1.92 2.24
Fixed Asset Turnover TTM 79.79 % 397.98 % 453.27 % 558.75 % 452.27 % 518.58 %
Asset Turnover TTM 13.35 % 55.77 % 39.66 % 54.66 % 41.04 % 36.3 %
Operating Cash Flow Per Share TTM -16.67 4.56 1.24 8.96 1.79 5.33
Free Cash Flow Per Share TTM -17.63 3.26 0.81 7.36 1.2 3.98
Cash Per Share TTM 1667.84 % 416.3 % 39.7 % 513.65 % 203.18 % 606.43 %
Operating Cash Flow Sales Ratio TTM -555.61 % 19.4 % 13.6 % 15.97 % 17.28 % 21.17 %
Free Cash Flow Operating Cash Flow Ratio TTM 105.81 % 71.57 % 65.5 % 82.08 % 66.83 % 74.59 %
Cash Flow Coverage Ratios TTM -1865.42 % 53.54 % 18.94 % 27.62 % 24.91 % 24.8 %
Price To Free Cash Flows Ratio TTM -0.14 34.86 103.65 49 68.47 22.08
Price To Operating Cash Flows Ratio TTM -0.01 24.86 66.2 40.21 45.7 16.61
Price Cash Flow Ratio TTM -0.01 24.86 66.2 40.21 45.7 16.61
Income Statement (TTM)
BJDX ABT BSX-PA SYK BSX MDT
Revenue $0B $40.11B $14.24B $20.5B $14.24B $32.36B
Gross Profit $-0B $22.13B $9.9B $13.06B $9.9B $19.45B
Gross Profit Ratio 0% 55.18% 69.49% 63.7% 69.49% 60.11%
EBITDA $-0.01B $10.59B $3.62B $4.95B $3.62B $8.38B
Net Income $-0.01B $5.72B $1.59B $3.17B $1.59B $3.68B
EPS Diluted -72.62 3.26 1.07 8.25 1.07 2.76
Balance Sheet (MRQ)
BJDX ABT BSX-PA SYK BSX MDT
Long Term Debt $0B $13.6B $8.96B $10.9B $8.96B $23.88B
Total Liabilities $0B $34.39B $15.61B $21.32B $15.61B $39.56B
Total Equity $0B $38.83B $19.53B $18.59B $19.53B $50.42B
Total Investments $0B $1.18B $0.41B $0.08B $0.41B $8.34B
Total Debt $0B $15.87B $9.49B $13B $9.49B $26.05B
Total Assets $0B $73.21B $35.14B $39.91B $35.14B $89.98B
Cash Flow Statement (TTM)
BJDX ABT BSX-PA SYK BSX MDT
Net Income $-0.01B $5.7B $1.59B $3.17B $1.59B $3.68B
Inventory $0B $-0.23B $-0.66B $-0.8B $-0.66B $-0.14B
Dividends Paid $0B $-3.56B $-0.03B $-1.14B $-0.03B $-3.67B
Operating Cash Flow $-0.01B $7.26B $2.5B $3.71B $2.5B $6.79B
Capital Expenditure $-0B $-2.2B $-0.8B $-0.58B $-0.8B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 113.27
AEMD Aethlon Medical, Inc. 0.38
AFIB Acutus Medical, Inc. 0.031
AHCO AdaptHealth Corp. 10.99
AHPI Allied Healthcare Products, Inc. 0.5501
ALGN Align Technology, Inc. 237.22
ALUR Allurion Technologies Inc. 0.6592
AMIX Autonomix Medical, Inc. Common Stock 0.67
ANIK Anika Therapeutics, Inc. 25.7
AORT Artivion, Inc. 27.14
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.33
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 6.9
AVNS Avanos Medical, Inc. 24.22
AXDX Accelerate Diagnostics, Inc. 1.9987
AXGN AxoGen, Inc. 13.15
AXNX Axonics, Inc. 69.165
AZYO Aziyo Biologics, Inc. 1.49
ETFs With Exposure to BJDX
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 179.52
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 136.29
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 136.3
VEMPX Vanguard Extended Market Index InstlPlus 0 336.35
Unlock